Tore Bengtsson is the founder and chief scientific officer of Atrogi AB and, together with a co-author, has applied for patents related to the compounds investigated in the research
Semaglutide and tirzepatide are GLP-1 receptor medications given as a weekly subcutaneous injection
Learn how to prepare for emerging threats and support long-term ambitions
229,245,285 In SUPRASS-CVOT, tirzepatide was found to be non-inferior to dulaglutide (HR 0.92
Clinical Context: Why Prescribers Consider Ipamorelin in Liver Disease Sarcopenia affects 40 to 70% of patients with cirrhosis and independently predicts mortality, transplant waitlist dropout, and post-transplant complications
Metoder til styring af teams og projekter: Teamledelse: Fokus p kommunikation, rollefordeling og motivation for at sikre et velfungerende samarbejde